Mutual Fund NFO: Subscription of HDFC Mutual Fund’s NFO HDFC Pharma and Healthcare Fund has opened from 14th September. This is an open ended scheme.
Mutual Fund NFO: Asset management company HDFC Mutual Fund has brought a new Sectoral Pharma Fund (NFO) in the equity segment. Subscription of the fund house’s NFO HDFC Pharma and Healthcare Fund has opened from September 14. Investors can apply for this scheme till 28 September 2023. This is an open ended scheme. In this, investors can make redemption whenever they want. According to the asset management company, the scheme can be helpful in long term capital appreciation.
You can start investing from ₹100
According to asset management company HDFC Mutual Fund, you can start investing in HDFC Pharma and Healthcare Fund with a minimum of Rs 100 and thereafter in multiples of Re 1. In this scheme, 1 percent exit load will have to be paid on redemption within 1 year. The benchmark of this scheme is S&P BSE Healthcare. The fund manager of this scheme is Nikhil Mathur. There is SIP facility in this scheme. You can invest in both regular and direct ways.
Who can invest
According to the mutual fund house, investors seeking capital appreciation in the long term can invest in this scheme. In this scheme, investors will get an opportunity to invest in equity and equity related instruments of pharma and health care companies. The objective of the scheme is to generate better returns through investments in pharma and healthcare companies. However, there is no guarantee of any kind in the scheme. The scheme will open again within 5 days from the date of allotment.
(Disclaimer: Only information about NFO is given here. This is not investment advice. Investing in mutual funds is subject to market risks. Consult your advisor before investing.)
